Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo

International Journal of Dermatology

Volumn 53, Issue 8, 2014, Pages 940-946

  Abdallah, Marwa ^a   Lotfi, Ranya ^a   Othman, Wessam ^a   Galal, Riham ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Air Force Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; VITILIGO; ADOLESCENT; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CHEMISTRY; CYTOLOGY; DERMIS; IMMUNOLOGY; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMIS; EPIDERMIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MALE; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; VITILIGO; YOUNG ADULT;

EID: 84904303862     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12160     Document Type: Article

References (26)

1. Taieb A. Immune/inflammatory aspects. In: Picardo M, Taïeb A, eds. Vitiligo. London: Springer, 2010: 239-240.
2. Le Poole IC, Wankowicz-Kalinska A, Van den Wijngaard RM, et al. Autoimmune aspects of depigmentation in vitiligo. J Invest Dermatol Symp Proc 2004; 9: 68-72.
3. Abanni A, ALHarti F, ALBaqami R, et al. Association of HLA loci alleles and antigens in saudi patients with vitiligo. Arch Dermatol 2006; 298: 347-352.
4. Liu JB, Li M, Chen H, et al. Association of vitiligo with HLA-A2: a meta analysis. J Eur Acad Dermatol Venereol 2007; 21: 205-213.
5. Wang J, Zhao YM, Wang Y, et al. Association of HLA class I and II alleles with generalized vitiligo in Chinese Han in north China. Shonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24: 221-223.
6. Wick G, Andersson L, Hala K, et al. Avian models with spontaneous autoimmune diseases. Adv Immunol 2006; 92: 71-117.
7. Tu CX, Gu JS, Lin XR, et al. Increased interleukin 6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 2003; 31: 73-78.
8. Abdallah M, Abdelnaser MB, Moussa MH, et al. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. Eur J Dermatol 2003; 13: 548-552.
9. + T-cells to type-1-like are associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-695.
10. Van den Boorn JG, Konijnenberg D, Dellemijn TA. Cytotoxic perilesional T cells cause in situ melanocytes apoptosis in vitiligo vulgaris skin. Pigment Cell Res 2007; 20: 328-335.
11. Baumgartner J, Wilson C, Palmer R, et al. Melanoma induces immunosuppression by up-regulating Foxp3 regulatory cells. J Surg Res 2007; 141: 72-77.
12. + regulatory T cells in vivo. JEM 2003; 189: 249-258.
13. Afzali B, Lpmbardi G, Lechler RI, et al. The role of T helper 17(Th17) and regulatory T cells (Tregs) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
14. De Boer OJ, Van der Loos CM, Teeling P, et al. Immunohistochemical analysis of regulatory T cell markers foxp3 and GITR on CD4+CD25 T cells in normal skin and inflammatory dermatosis. J Histochem Cytochem 2007; 55: 891-898.
15. + FOXP3 T lymphocytes in active non-segmental vitiligo. Panarab Derm 2009; 20: 116-127.
16. Le Poole IC, Van den Wijngaard RM, Westerhof W, et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-1228.
17. Das PK, Van den Wijngaard RM, Wankowicz-Kalinska A, et al. A symbiotic concept of autoimmunity and tumor immunity lessons from vitiligo. Trends Immunol 2001; 22: 130-136.
18. Denman CJ, McCracken J, Hariharan V, et al. HSP70i accelerates depigmentation in a mouth model of autoimmune vitiligo. J Inv Dermatol 2008; 128: 2014-2048.
19. Visseren MJ, Van Elsas A, Van Der Voort EI, et al. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood can lyse melanoma cells. J Immunol 1995; 154: 3991-3998.
20. + T-cells at the perilesional site. Lab Invest 2000; 80: 1299-1309.
21. + T-cell ratio. Wien Med Wochenschr 2009; 159: 337-341.
22. Le Poole IC, Denman CJ, Arbiser JL. Immunosuppression may be present within condylomata acuminata. J Am Acad Dermatol 2008; 59: 967-974.
23. Klarquist J, Cecele JD, Hernandez C, et al. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res 2010; 23: 276-286.
24. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174: 164-173.
25. Bisikirska B, Colgan J, Luban J, et al. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115: 2904-2913.
26. Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005; 66: 13-20.